A Study to Evaluate ELX/TEZ/IVA on Cough and Physical Activity in Participants With Cystic Fibrosis (CF)

Clinical trial NCT04969224 · COMPLETED

Trial details

NCT number: NCT04969224
Sponsor: Vertex Pharmaceuticals Incorporated
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Cystic Fibrosis

Start date: 2021-10-12
Primary completion: 2022-07-26
Enrollment: 82

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.